Fenofibric Acid Capsule, Delayed Release
Product Images NDC 33342-294

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Fenofibric Acid (NDC 33342-294). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

174 (Fenofibric Acid 135 mg 10x14s)

174 (Fenofibric Acid 135 mg 10x14s)
This text appears to be a description of medication packaging for Fenofibric Acid Delayed-Release Capsules manufactured by Macleods Pharma USA. The capsules come in a packaging of 140 capsules (10 x 14 unit-doses) and each capsule contains 135 mg of fenofibric acid. It provides storage instructions to be kept at room temperature and protected from moisture. The medication is not child-resistant, and full prescribing information is available in the package insert.*
FDA Label Image

164 (Fenofibric Acid 135 mg 90s)

164 (Fenofibric Acid 135 mg 90s)
Pharma USA offers Delayed-Release Capsules containing Fenofibric Acid, with each capsule equivalent to 135 mg of fenofibric acid. The packaging includes 90 capsules. It is essential to store the product at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F) to maintain its integrity. The product includes warnings about not accepting the product if the seal is broken or missing. This pharmaceutical product is manufactured by Macleods Pharmaceuticals Ltd. in India and distributed by Macleods Pharma USA, Inc. It is crucial to keep this and all drugs out of the reach of children. Further prescribing information can be found in the package insert.*
FDA Label Image

163 (Fenofibric Acid 45 mg 10x10s)

163 (Fenofibric Acid 45 mg 10x10s)
This is a description of a medication called Fenofibric Acid Delayed-Release Capsules in the strength of 45 mg. The medication comes in a pack of 100 capsules within 10 unit-doses. It is manufactured by Macleods Pharma in the USA and India. The capsules should be stored between 20°C to 25°C (68°F to 77°F) and protected from moisture. Additionally, the text advises keeping the medication out of reach of children and notes that the blister cards are not child-resistant.*
FDA Label Image

186 (Fenofibric Acid 45 mg 90s)

186 (Fenofibric Acid 45 mg 90s)
This is a description of a medication called MACLEODD, which is a delayed-release capsule containing choline fenofibrate equivalent to 45 mg of fenofibric acid. It is manufactured by Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. in India. The capsules should be store at 20° to 25°C (68° to 77°F) and protect from moisture. The package insert contains full prescribing information. It is important to keep this medication out of the reach of children and not accept if the seal over bottle opening is broken or missing.*
FDA Label Image

111 (Fenofibric Acid Structure)

111 (Fenofibric Acid Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.